Indian Business-to-business-to-consumer dental products company Laxmi Dental Q2FY27: revenue of approximately RMB 55.97 million, up 10.04% year-on-year

Source: Laxmi Dental FY2027 Q2 Earnings Report

DentalGoodNews｜On November 3, 2026, Indian dental products company Laxmi Dental Limited (hereinafter referred to as "Laxmi Dental") announced its unaudited results for the second quarter of fiscal year 2027 ended September 30, 2026: on a consolidated basis, second-quarter Operating revenue was INR 795 million (approximately RMB 55.97 million), up 10.04% year-over-year; Net Profit Attributable to Shareholders of the Parent Company (hereinafter referred to as net profit attributable to the parent) was INR 100 million (approximately RMB 7.04 million), up 17.56% year-over-year.

In the first half of fiscal year 2027 (April 1 to September 30, 2026), the company's Operating revenue was INR 1,542 million (approximately RMB 109 million), up 11.86% year-over-year; net profit attributable to the parent was INR 203 million (approximately RMB 14.29 million), up 20.14% year-over-year. Compared with INR 747 million (approximately RMB 52.59 million) in the previous quarter, second-quarter Operating revenue grew 6.46% quarter-over-quarter.

By business segment, the Invisible orthodontics segment reported second-quarter revenue of INR 255 million (approximately RMB 17.95 million), up 25.19% year-over-year; first-half cumulative revenue was INR 497 million (approximately RMB 34.99 million), up 27.05% year-over-year. This segment includes Invisible braces, retainers, aligner raw materials, sports mouthguards, night bruxism guards, and sleep apnea devices, among others.

The Dental Laboratory Business reported second-quarter segment revenue of INR 542 million (approximately RMB 38.16 million), up 8.41% year-over-year; first-half cumulative revenue was INR 1,045 million (approximately RMB 73.57 million), up 10.46% year-over-year.

Other businesses include distribution products for dental laboratories, dental clinical services, and dental education courses. Second-quarter segment revenue was INR 11 million (approximately RMB 770,000), compared with INR 24 million (approximately RMB 1.69 million) in the same period last year, down 55.35% year-over-year. The above segment revenues all include inter-segment revenue and differ from the consolidated Operating revenue basis after elimination of inter-segment revenue.

Regarding changes in the profit structure, in the first half, the Dental Laboratory segment result declined from INR 175 million (approximately RMB 12.32 million) in the same period last year to INR 154 million (approximately RMB 10.84 million), down 12.02% year-over-year; over the same period, the Invisible orthodontics segment result rose from INR 61 million (approximately RMB 4.29 million) to INR 139 million (approximately RMB 9.79 million), up approximately 126.93% year-over-year.

In the first half, the segment revenue of the laboratory business remained higher than that of the Invisible orthodontics business, but the segment result gap between the two narrowed from INR 114 million (approximately RMB 8.03 million) in the same period last year to INR 15 million (approximately RMB 1.06 million) in the current period, with the laboratory business still slightly higher.

Source: Laxmi Dental FY2027 Q2 Earnings Report

Regarding profit growth, in the first half, the parent company's standalone net profit was INR 108 million (approximately RMB 7.60 million), down 24.84% year-over-year; second-quarter standalone net profit was INR 47 million (approximately RMB 3.31 million), down 28.86% year-over-year..

Regarding cash flow, in the first half, net cash flow from operating activities was an inflow of INR 152 million (approximately RMB 10.70 million), compared with a net outflow of INR 200 million (approximately RMB 14.08 million) in the same period last year; net cash flow from investing activities was an outflow of INR 144 million (approximately RMB 10.14 million), including INR 167 million (approximately RMB 11.76 million) in capital expenditure on property, plant and equipment.

Cash and cash equivalents at the end of the period were INR 61 million (approximately RMB 4.29 million), lower than INR 84 million (approximately RMB 5.91 million) at the beginning of the period. Over the same period, the company's consolidated total assets increased from INR 2,940 million (approximately RMB 207 million) at the end of March 2026 to INR 3,164 million (approximately RMB 223 million) at the end of September 2026.

Source: Laxmi Dental FY2027 Q2 Earnings Report

Regarding the use of funds, the company disclosed that shareholders at the 22nd Annual General Meeting held on September 25, 2026 passed a special resolution approving the adjustment of the use of part of the proceeds from the Initial Public Offering (IPO) and the extension of the utilization period. The newly added uses include the purchase of land and the construction of factory buildings and infrastructure for the Dental Laboratory and Invisible orthodontics facilities, with a planned investment of INR 269 million (approximately RMB 18.94 million); and the purchase of movable assets such as machinery, computers, and furniture for existing or new premises, with a planned investment of INR 212 million (approximately RMB 14.92 million).

The relevant funds are planned to be used during fiscal years 2026-27 and 2027-28. As of September 30, 2026, cumulative utilization of IPO proceeds was INR 814 million (approximately RMB 57.31 million), with INR 468 million (approximately RMB 32.95 million) unused, and the unused portion is temporarily placed in bank time deposits.